Is activists’ favourite suicide drug “torturous”?
Controversy over Oklahoma execution
It is unlikely to derail activists, but the
drug of choice for assisted suicide activists is being described as “untested,
[and] potentially dangerous, and could well result in a torturous execution” of
an Oklahoma man on death row. The state has run out of thiopental sodium, which
is used for lethal injections in the US. Hence it want to use pentobarbital –
also known as Nembutal – which is used for putting down animals. But John David
Duty’s lawyers claim that this could constitute cruel and unusual punishment. It
may not thoroughly anaesthetise prisoners and may cause them severe pain.
This puts an interesting twist on
euthanasia rhetoric. “I wouldn’t let a dog suffer like that” is a familiar
argument for assisted suicide activists like Philip Nitschke, of Exit
International, or Ludwig Minelli, of Dignitas. So they offer their clients Nembutal.
Now, however, it turns out, Nembutal might make you suffer like the proverbial dog.
~ Wall
Street Journal, Nov 9
Michael Cook
assisted suicide
capital punishment
euthanasia
Nembutal
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...